Iniciar sesión Regístrese gratis

Theratechnologies Ingresos

¿Qué es el Ingresos de Theratechnologies?

El Ingresos de Theratechnologies, Inc. es -$7.00

¿Cuál es la definición de Ingresos?

El ingreso neto disponible para los accionistas comunes es igual al ingreso neto menos los dividendos preferentes pagados.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Ingresos de compañías en Sector Health Care en TSX en comparadas con Theratechnologies

¿Qué hace Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Empresas con ingresos similar a Theratechnologies